

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle contraction (GO:0003009) | 6.26291522 |
| 2 | actin filament-based movement (GO:0030048) | 5.27896991 |
| 3 | sarcomere organization (GO:0045214) | 5.10827480 |
| 4 | cardiac myofibril assembly (GO:0055003) | 4.53489745 |
| 5 | response to muscle activity (GO:0014850) | 4.50316051 |
| 6 | muscle contraction (GO:0006936) | 4.49664281 |
| 7 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.44909999 |
| 8 | response to inactivity (GO:0014854) | 4.37719564 |
| 9 | myofibril assembly (GO:0030239) | 4.35127246 |
| 10 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.15609348 |
| 11 | muscle system process (GO:0003012) | 4.02754975 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.99610559 |
| 13 | regulation of actin filament-based movement (GO:1903115) | 3.97452478 |
| 14 | tricarboxylic acid cycle (GO:0006099) | 3.94557340 |
| 15 | regulation of sequestering of triglyceride (GO:0010889) | 3.92114994 |
| 16 | glycogen catabolic process (GO:0005980) | 3.91821602 |
| 17 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.88959963 |
| 18 | muscle hypertrophy in response to stress (GO:0003299) | 3.88959963 |
| 19 | cardiac muscle adaptation (GO:0014887) | 3.88959963 |
| 20 | cell communication by electrical coupling (GO:0010644) | 3.82701500 |
| 21 | fatty acid beta-oxidation (GO:0006635) | 3.82248152 |
| 22 | creatine metabolic process (GO:0006600) | 3.79694850 |
| 23 | regulation of membrane repolarization (GO:0060306) | 3.78506754 |
| 24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.75199135 |
| 25 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.74038635 |
| 26 | regulation of skeletal muscle contraction (GO:0014819) | 3.73124564 |
| 27 | skeletal muscle fiber development (GO:0048741) | 3.70570355 |
| 28 | actin-myosin filament sliding (GO:0033275) | 3.69206749 |
| 29 | muscle filament sliding (GO:0030049) | 3.69206749 |
| 30 | striated muscle adaptation (GO:0014888) | 3.67670828 |
| 31 | respiratory electron transport chain (GO:0022904) | 3.66316469 |
| 32 | regulation of relaxation of muscle (GO:1901077) | 3.65023755 |
| 33 | glucan catabolic process (GO:0009251) | 3.64104991 |
| 34 | heart contraction (GO:0060047) | 3.60881773 |
| 35 | heart process (GO:0003015) | 3.60881773 |
| 36 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.59937776 |
| 37 | * regulation of calcium ion transmembrane transport (GO:1903169) | 3.58974430 |
| 38 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.58974430 |
| 39 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.57972446 |
| 40 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.57971175 |
| 41 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.55582409 |
| 42 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.55582409 |
| 43 | electron transport chain (GO:0022900) | 3.55228837 |
| 44 | skeletal muscle adaptation (GO:0043501) | 3.53976362 |
| 45 | carnitine shuttle (GO:0006853) | 3.52938860 |
| 46 | cardiac muscle contraction (GO:0060048) | 3.50655410 |
| 47 | detection of calcium ion (GO:0005513) | 3.43723788 |
| 48 | negative regulation of protein localization to cell surface (GO:2000009) | 3.42117301 |
| 49 | fatty acid transmembrane transport (GO:1902001) | 3.41425940 |
| 50 | aspartate family amino acid catabolic process (GO:0009068) | 3.40010948 |
| 51 | cellular polysaccharide catabolic process (GO:0044247) | 3.38391822 |
| 52 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.35927025 |
| 53 | ATP synthesis coupled proton transport (GO:0015986) | 3.35759724 |
| 54 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.35759724 |
| 55 | 2-oxoglutarate metabolic process (GO:0006103) | 3.34224765 |
| 56 | fatty acid catabolic process (GO:0009062) | 3.34189102 |
| 57 | lipid oxidation (GO:0034440) | 3.31527942 |
| 58 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.31231241 |
| 59 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.31093659 |
| 60 | fatty acid oxidation (GO:0019395) | 3.29167078 |
| 61 | myotube cell development (GO:0014904) | 3.28206580 |
| 62 | oxaloacetate metabolic process (GO:0006107) | 3.26536981 |
| 63 | adult heart development (GO:0007512) | 3.25443929 |
| 64 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.23993211 |
| 65 | * positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.23954722 |
| 66 | branched-chain amino acid catabolic process (GO:0009083) | 3.21597660 |
| 67 | gluconeogenesis (GO:0006094) | 3.19623268 |
| 68 | glycogen biosynthetic process (GO:0005978) | 3.18974083 |
| 69 | glucan biosynthetic process (GO:0009250) | 3.18974083 |
| 70 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.18450597 |
| 71 | cardiac muscle cell development (GO:0055013) | 3.11653070 |
| 72 | regulation of heart rate (GO:0002027) | 3.10639380 |
| 73 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.10330807 |
| 74 | muscle fiber development (GO:0048747) | 3.09891544 |
| 75 | short-chain fatty acid metabolic process (GO:0046459) | 3.09338612 |
| 76 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.09289322 |
| 77 | actomyosin structure organization (GO:0031032) | 3.08964696 |
| 78 | muscle cell cellular homeostasis (GO:0046716) | 3.08926737 |
| 79 | polysaccharide catabolic process (GO:0000272) | 3.07941677 |
| 80 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.07000545 |
| 81 | cardiac muscle cell action potential (GO:0086001) | 3.06554025 |
| 82 | actin-mediated cell contraction (GO:0070252) | 3.06113776 |
| 83 | lysine catabolic process (GO:0006554) | 3.04341465 |
| 84 | lysine metabolic process (GO:0006553) | 3.04341465 |
| 85 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.03751627 |
| 86 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.03353384 |
| 87 | plasma membrane repair (GO:0001778) | 3.02846765 |
| 88 | regulation of ATPase activity (GO:0043462) | 3.02785464 |
| 89 | regulation of ATP catabolic process (GO:1903289) | 3.02785464 |
| 90 | relaxation of muscle (GO:0090075) | 3.02436746 |
| 91 | sodium ion export (GO:0071436) | 3.01181737 |
| 92 | cardiac cell development (GO:0055006) | 2.99849549 |
| 93 | regulation of striated muscle contraction (GO:0006942) | 2.99718469 |
| 94 | regulation of lipoprotein metabolic process (GO:0050746) | 2.98994690 |
| 95 | heart trabecula formation (GO:0060347) | 2.96544226 |
| 96 | cellular response to epinephrine stimulus (GO:0071872) | 2.96170035 |
| 97 | positive regulation of sodium ion transport (GO:0010765) | 2.95658849 |
| 98 | monocarboxylic acid catabolic process (GO:0072329) | 2.94946906 |
| 99 | * regulation of heart contraction (GO:0008016) | 2.94912163 |
| 100 | muscle tissue morphogenesis (GO:0060415) | 2.94546479 |
| 101 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.94530282 |
| 102 | branched-chain amino acid metabolic process (GO:0009081) | 2.94493583 |
| 103 | response to epinephrine (GO:0071871) | 2.93921031 |
| 104 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.93755149 |
| 105 | muscle adaptation (GO:0043500) | 2.92905016 |
| 106 | skeletal muscle tissue development (GO:0007519) | 2.92717917 |
| 107 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.92406432 |
| 108 | carnitine transmembrane transport (GO:1902603) | 2.92272648 |
| 109 | hexose biosynthetic process (GO:0019319) | 2.86004041 |
| 110 | amino-acid betaine transport (GO:0015838) | 2.83747123 |
| 111 | carnitine transport (GO:0015879) | 2.83747123 |
| 112 | valine metabolic process (GO:0006573) | 2.83184136 |
| 113 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.82254776 |
| 114 | regulation of fatty acid oxidation (GO:0046320) | 2.79460739 |
| 115 | cardiac muscle hypertrophy (GO:0003300) | 2.78764191 |
| 116 | acetyl-CoA metabolic process (GO:0006084) | 2.77665540 |
| 117 | cellular ketone body metabolic process (GO:0046950) | 2.74404615 |
| 118 | axon ensheathment in central nervous system (GO:0032291) | 2.74002470 |
| 119 | central nervous system myelination (GO:0022010) | 2.74002470 |
| 120 | biotin metabolic process (GO:0006768) | 2.71279743 |
| 121 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.70975278 |
| 122 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.70799566 |
| 123 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.67960498 |
| 124 | striated muscle hypertrophy (GO:0014897) | 2.65511025 |
| 125 | striated muscle contraction (GO:0006941) | 2.65486568 |
| 126 | tricarboxylic acid metabolic process (GO:0072350) | 2.64421426 |
| 127 | muscle hypertrophy (GO:0014896) | 2.63284689 |
| 128 | regulation of cardiac muscle contraction (GO:0055117) | 2.62998258 |
| 129 | regulation of the force of heart contraction (GO:0002026) | 2.62874663 |
| 130 | regulation of coenzyme metabolic process (GO:0051196) | 2.62573768 |
| 131 | regulation of cofactor metabolic process (GO:0051193) | 2.62573768 |
| 132 | regulation of cell communication by electrical coupling (GO:0010649) | 2.60451736 |
| 133 | regulation of sarcomere organization (GO:0060297) | 2.58370331 |
| 134 | carnitine metabolic process (GO:0009437) | 2.56505190 |
| 135 | ethanol oxidation (GO:0006069) | 2.53897797 |
| 136 | oxidative phosphorylation (GO:0006119) | 2.48463288 |
| 137 | relaxation of cardiac muscle (GO:0055119) | 2.48434787 |
| 138 | cell communication involved in cardiac conduction (GO:0086065) | 2.47561126 |
| 139 | positive regulation of fatty acid oxidation (GO:0046321) | 2.47327188 |
| 140 | glyoxylate metabolic process (GO:0046487) | 2.46552750 |
| 141 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.46247813 |
| 142 | quaternary ammonium group transport (GO:0015697) | 2.42561025 |
| 143 | regulation of triglyceride catabolic process (GO:0010896) | 2.41393940 |
| 144 | thyroid hormone generation (GO:0006590) | 2.40948280 |
| 145 | L-phenylalanine catabolic process (GO:0006559) | 2.39604360 |
| 146 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.39604360 |
| 147 | response to mercury ion (GO:0046689) | 2.38636275 |
| 148 | NADH metabolic process (GO:0006734) | 2.38620718 |
| 149 | ketone body metabolic process (GO:1902224) | 2.37358441 |
| 150 | regulation of cholesterol metabolic process (GO:0090181) | 2.34840711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.51305502 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.14625027 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.45745132 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.39600279 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.89560929 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.68766709 |
| 7 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.67927227 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.62240765 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.60308007 |
| 10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.53984041 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.52850280 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.50882114 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46449207 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.24402724 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.14694199 |
| 16 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.13583519 |
| 17 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.13583519 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.07565752 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.06715768 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.02235928 |
| 21 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.97198183 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.91844101 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.88508303 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.87012866 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84387191 |
| 26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.83603443 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.82064001 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.76719879 |
| 29 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69194454 |
| 30 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.67994356 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.67932292 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67648452 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65050079 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62911942 |
| 35 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.60680987 |
| 36 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.60680987 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.58032470 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55138441 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55138441 |
| 40 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.53336560 |
| 41 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.53163118 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50813620 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50453840 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49859947 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49472601 |
| 46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.49160954 |
| 47 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.45238250 |
| 48 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.44286267 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41844053 |
| 50 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.41686235 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.41641730 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40194332 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39770643 |
| 54 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.38724464 |
| 55 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36842454 |
| 56 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.35960488 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35661165 |
| 58 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33147725 |
| 59 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29441518 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29439019 |
| 61 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29233241 |
| 62 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28621900 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28284733 |
| 64 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26851155 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24594886 |
| 66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24437964 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23660990 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22895631 |
| 69 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.21115525 |
| 70 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.20904594 |
| 71 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.17438279 |
| 72 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.17139326 |
| 73 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.16986367 |
| 74 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.16611148 |
| 75 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12786577 |
| 76 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12575561 |
| 77 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12132064 |
| 78 | CJUN_26792858_Chip-Seq_BT549_Human | 1.11002016 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07865660 |
| 80 | P68_20966046_ChIP-Seq_HELA_Human | 1.07684955 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06873995 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06620112 |
| 83 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06381178 |
| 84 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.06160113 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05552522 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05293267 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04448236 |
| 88 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03987002 |
| 89 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03922135 |
| 90 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.02740532 |
| 91 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.01760451 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00956757 |
| 93 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00287846 |
| 94 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.00271484 |
| 95 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99728373 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98557597 |
| 97 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97860534 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97669488 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97478577 |
| 100 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.95886519 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95577657 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95345133 |
| 103 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94386982 |
| 104 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94192864 |
| 105 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94036550 |
| 106 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.93912457 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93812020 |
| 108 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.93477766 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93270497 |
| 110 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.92182424 |
| 111 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.91924151 |
| 112 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91911760 |
| 113 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.90882686 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90548658 |
| 115 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88526251 |
| 116 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87372791 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87284804 |
| 118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86968257 |
| 119 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86401607 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85278186 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84431853 |
| 122 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.84357565 |
| 123 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84275822 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84014451 |
| 125 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.83484351 |
| 126 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.83476203 |
| 127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83394128 |
| 128 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82693751 |
| 129 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82515774 |
| 130 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81861701 |
| 131 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.79588816 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77610875 |
| 133 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76692910 |
| 134 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.76365848 |
| 135 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75984670 |
| 136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.75383278 |
| 137 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75269869 |
| 138 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74959747 |
| 139 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.74502845 |
| 140 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.74116926 |
| 141 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74039926 |
| 142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72549321 |
| 143 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.72299291 |
| 144 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.71487422 |
| 145 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70678818 |
| 146 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.70357158 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70218689 |
| 148 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.69995697 |
| 149 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.69386783 |
| 150 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.68942393 |
| 151 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68832134 |
| 152 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.68390821 |
| 153 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68183267 |
| 154 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.67418592 |
| 155 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.66908412 |
| 156 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.66661866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.54433941 |
| 2 | MP0003646_muscle_fatigue | 4.47212932 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.04539862 |
| 4 | MP0000751_myopathy | 3.35316209 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.22887205 |
| 6 | MP0004215_abnormal_myocardial_fiber | 3.20481225 |
| 7 | MP0000749_muscle_degeneration | 2.97648542 |
| 8 | MP0005330_cardiomyopathy | 2.90962356 |
| 9 | MP0004130_abnormal_muscle_cell | 2.49374870 |
| 10 | * MP0002972_abnormal_cardiac_muscle | 2.40276824 |
| 11 | MP0008775_abnormal_heart_ventricle | 2.31990530 |
| 12 | MP0004043_abnormal_pH_regulation | 2.19085766 |
| 13 | MP0004087_abnormal_muscle_fiber | 2.13029019 |
| 14 | MP0004233_abnormal_muscle_weight | 2.10613868 |
| 15 | MP0005385_cardiovascular_system_phenoty | 2.01369651 |
| 16 | MP0001544_abnormal_cardiovascular_syste | 2.01369651 |
| 17 | MP0004270_analgesia | 1.95143173 |
| 18 | MP0000750_abnormal_muscle_regeneration | 1.88983403 |
| 19 | MP0003137_abnormal_impulse_conducting | 1.88285453 |
| 20 | MP0003195_calcinosis | 1.84605630 |
| 21 | * MP0005620_abnormal_muscle_contractility | 1.83484824 |
| 22 | MP0006138_congestive_heart_failure | 1.81209467 |
| 23 | MP0005670_abnormal_white_adipose | 1.79717383 |
| 24 | MP0000343_altered_response_to | 1.77682701 |
| 25 | MP0005666_abnormal_adipose_tissue | 1.76205207 |
| 26 | MP0003828_pulmonary_edema | 1.75833175 |
| 27 | MP0004484_altered_response_of | 1.74864963 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.74642119 |
| 29 | MP0009840_abnormal_foam_cell | 1.73850440 |
| 30 | MP0003690_abnormal_glial_cell | 1.72797859 |
| 31 | MP0010630_abnormal_cardiac_muscle | 1.72295319 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.64707253 |
| 33 | MP0003186_abnormal_redox_activity | 1.63898502 |
| 34 | MP0004859_abnormal_synaptic_plasticity | 1.58568594 |
| 35 | MP0004510_myositis | 1.57919379 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.56592278 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.56366287 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.54628580 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.52657249 |
| 40 | * MP0002106_abnormal_muscle_physiology | 1.50490775 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.47894789 |
| 42 | MP0008569_lethality_at_weaning | 1.47274546 |
| 43 | MP0005165_increased_susceptibility_to | 1.40742484 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.38481605 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.33736004 |
| 46 | MP0000733_abnormal_muscle_development | 1.32586651 |
| 47 | MP0000920_abnormal_myelination | 1.31532769 |
| 48 | MP0005360_urolithiasis | 1.30617734 |
| 49 | MP0002269_muscular_atrophy | 1.29699448 |
| 50 | MP0004085_abnormal_heartbeat | 1.29622965 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.29495549 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.27829103 |
| 53 | MP0005332_abnormal_amino_acid | 1.27366016 |
| 54 | MP0003279_aneurysm | 1.26102885 |
| 55 | MP0000747_muscle_weakness | 1.24558800 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.24411294 |
| 57 | MP0008438_abnormal_cutaneous_collagen | 1.22312961 |
| 58 | * MP0005369_muscle_phenotype | 1.21591301 |
| 59 | MP0000013_abnormal_adipose_tissue | 1.17532389 |
| 60 | MP0000759_abnormal_skeletal_muscle | 1.16251683 |
| 61 | MP0005375_adipose_tissue_phenotype | 1.14007890 |
| 62 | MP0005365_abnormal_bile_salt | 1.12832127 |
| 63 | MP0005423_abnormal_somatic_nervous | 1.12724544 |
| 64 | MP0002295_abnormal_pulmonary_circulatio | 1.11606212 |
| 65 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11105889 |
| 66 | MP0002118_abnormal_lipid_homeostasis | 1.09341155 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.09115050 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 1.07265499 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07030220 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.06705723 |
| 71 | MP0010368_abnormal_lymphatic_system | 1.05808802 |
| 72 | MP0003075_altered_response_to | 1.03750431 |
| 73 | MP0003724_increased_susceptibility_to | 1.02670204 |
| 74 | MP0003879_abnormal_hair_cell | 1.00785801 |
| 75 | MP0005409_darkened_coat_color | 1.00359817 |
| 76 | MP0004381_abnormal_hair_follicle | 0.97806144 |
| 77 | MP0000230_abnormal_systemic_arterial | 0.94670967 |
| 78 | MP0001879_abnormal_lymphatic_vessel | 0.93452839 |
| 79 | MP0003329_amyloid_beta_deposits | 0.92297447 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.92288971 |
| 81 | MP0002064_seizures | 0.91773723 |
| 82 | MP0010329_abnormal_lipoprotein_level | 0.91694250 |
| 83 | MP0005535_abnormal_body_temperature | 0.90946397 |
| 84 | MP0001853_heart_inflammation | 0.88396306 |
| 85 | MP0003878_abnormal_ear_physiology | 0.87117850 |
| 86 | MP0005377_hearing/vestibular/ear_phenot | 0.87117850 |
| 87 | MP0001958_emphysema | 0.86755388 |
| 88 | MP0003635_abnormal_synaptic_transmissio | 0.84367161 |
| 89 | MP0002127_abnormal_cardiovascular_syste | 0.83048102 |
| 90 | MP0000604_amyloidosis | 0.82859298 |
| 91 | MP0004145_abnormal_muscle_electrophysio | 0.82096908 |
| 92 | MP0000372_irregular_coat_pigmentation | 0.81841996 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 0.80764075 |
| 94 | MP0002272_abnormal_nervous_system | 0.79381606 |
| 95 | MP0005451_abnormal_body_composition | 0.77962306 |
| 96 | MP0002971_abnormal_brown_adipose | 0.76944110 |
| 97 | MP0009764_decreased_sensitivity_to | 0.76810159 |
| 98 | MP0002822_catalepsy | 0.76358901 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.72637917 |
| 100 | MP0000266_abnormal_heart_morphology | 0.70656529 |
| 101 | MP0003011_delayed_dark_adaptation | 0.69930934 |
| 102 | MP0002090_abnormal_vision | 0.69630032 |
| 103 | MP0003705_abnormal_hypodermis_morpholog | 0.68711908 |
| 104 | MP0005408_hypopigmentation | 0.67816284 |
| 105 | MP0003136_yellow_coat_color | 0.66823368 |
| 106 | MP0009745_abnormal_behavioral_response | 0.66543712 |
| 107 | MP0005083_abnormal_biliary_tract | 0.66273237 |
| 108 | MP0002734_abnormal_mechanical_nocicepti | 0.65780024 |
| 109 | MP0006082_CNS_inflammation | 0.65520619 |
| 110 | MP0002128_abnormal_blood_circulation | 0.65301653 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 0.65249949 |
| 112 | MP0004272_abnormal_basement_membrane | 0.64089996 |
| 113 | MP0003172_abnormal_lysosome_physiology | 0.63719280 |
| 114 | MP0005171_absent_coat_pigmentation | 0.63276343 |
| 115 | MP0001756_abnormal_urination | 0.62818661 |
| 116 | MP0003045_fibrosis | 0.61561654 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.61469450 |
| 118 | * MP0002063_abnormal_learning/memory/cond | 0.61198744 |
| 119 | MP0000249_abnormal_blood_vessel | 0.59891461 |
| 120 | MP0002066_abnormal_motor_capabilities/c | 0.59786313 |
| 121 | MP0001661_extended_life_span | 0.59586659 |
| 122 | MP0005266_abnormal_metabolism | 0.57645855 |
| 123 | MP0000609_abnormal_liver_physiology | 0.57422501 |
| 124 | MP0001502_abnormal_circadian_rhythm | 0.57245130 |
| 125 | MP0005166_decreased_susceptibility_to | 0.57015727 |
| 126 | MP0003634_abnormal_glial_cell | 0.56530943 |
| 127 | MP0001486_abnormal_startle_reflex | 0.55857368 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.55757450 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.55654658 |
| 130 | MP0008469_abnormal_protein_level | 0.54775881 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.53990855 |
| 132 | MP0001501_abnormal_sleep_pattern | 0.51588759 |
| 133 | MP0003633_abnormal_nervous_system | 0.47794534 |
| 134 | MP0004858_abnormal_nervous_system | 0.46922256 |
| 135 | MP0003880_abnormal_central_pattern | 0.42202384 |
| 136 | MP0002638_abnormal_pupillary_reflex | 0.41452452 |
| 137 | MP0008260_abnormal_autophagy | 0.40501661 |
| 138 | MP0001984_abnormal_olfaction | 0.38917405 |
| 139 | * MP0002572_abnormal_emotion/affect_behav | 0.38555264 |
| 140 | MP0004924_abnormal_behavior | 0.38398812 |
| 141 | MP0005386_behavior/neurological_phenoty | 0.38398812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.71078701 |
| 2 | Nemaline bodies (HP:0003798) | 7.64407642 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.47768463 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 6.58412059 |
| 5 | Sudden death (HP:0001699) | 5.23403315 |
| 6 | Ventricular tachycardia (HP:0004756) | 5.04477090 |
| 7 | Muscle fiber splitting (HP:0003555) | 4.77233223 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 4.44399342 |
| 9 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.34747153 |
| 10 | Myopathic facies (HP:0002058) | 4.34318447 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 4.24141188 |
| 12 | Atrial fibrillation (HP:0005110) | 4.22700549 |
| 13 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.11713142 |
| 14 | Neck muscle weakness (HP:0000467) | 4.09231693 |
| 15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.05096085 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.99687485 |
| 17 | Lipoatrophy (HP:0100578) | 3.95522371 |
| 18 | Primary atrial arrhythmia (HP:0001692) | 3.86555062 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 3.83423242 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 3.81221756 |
| 21 | Myoglobinuria (HP:0002913) | 3.78805860 |
| 22 | Distal arthrogryposis (HP:0005684) | 3.78787426 |
| 23 | Increased variability in muscle fiber diameter (HP:0003557) | 3.76713421 |
| 24 | Abnormality of the calf musculature (HP:0001430) | 3.72131805 |
| 25 | Supraventricular tachycardia (HP:0004755) | 3.68966705 |
| 26 | Dilated cardiomyopathy (HP:0001644) | 3.64358867 |
| 27 | Round ear (HP:0100830) | 3.63013675 |
| 28 | Supraventricular arrhythmia (HP:0005115) | 3.60407405 |
| 29 | EMG: neuropathic changes (HP:0003445) | 3.51507440 |
| 30 | Palpitations (HP:0001962) | 3.50021017 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40783876 |
| 32 | Rimmed vacuoles (HP:0003805) | 3.40170132 |
| 33 | Hepatic necrosis (HP:0002605) | 3.39157793 |
| 34 | Ketoacidosis (HP:0001993) | 3.37113233 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 3.34061527 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.33598869 |
| 37 | Syncope (HP:0001279) | 3.22359757 |
| 38 | Axonal loss (HP:0003447) | 3.18547595 |
| 39 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.15829198 |
| 40 | Dicarboxylic aciduria (HP:0003215) | 3.15829198 |
| 41 | Ulnar deviation of the wrist (HP:0003049) | 3.14336104 |
| 42 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.12711012 |
| 43 | Subaortic stenosis (HP:0001682) | 3.12711012 |
| 44 | Areflexia of lower limbs (HP:0002522) | 3.11302693 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 3.07963862 |
| 46 | Acute necrotizing encephalopathy (HP:0006965) | 3.07930726 |
| 47 | Acute encephalopathy (HP:0006846) | 3.04109712 |
| 48 | Abnormality of the foot musculature (HP:0001436) | 3.01743123 |
| 49 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.99841048 |
| 50 | EMG: myopathic abnormalities (HP:0003458) | 2.98385791 |
| 51 | Increased muscle lipid content (HP:0009058) | 2.98013461 |
| 52 | Cerebral edema (HP:0002181) | 2.96152542 |
| 53 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.93780164 |
| 54 | Ketosis (HP:0001946) | 2.91868602 |
| 55 | Frequent falls (HP:0002359) | 2.89742432 |
| 56 | Hepatocellular necrosis (HP:0001404) | 2.88984120 |
| 57 | Rhabdomyolysis (HP:0003201) | 2.87515178 |
| 58 | Prolonged QT interval (HP:0001657) | 2.85782408 |
| 59 | Foot dorsiflexor weakness (HP:0009027) | 2.84584748 |
| 60 | Bundle branch block (HP:0011710) | 2.83738109 |
| 61 | Bulbar palsy (HP:0001283) | 2.80846927 |
| 62 | Atrioventricular block (HP:0001678) | 2.77029433 |
| 63 | Mitochondrial inheritance (HP:0001427) | 2.76541018 |
| 64 | Heart block (HP:0012722) | 2.75374467 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.73864277 |
| 66 | Ragged-red muscle fibers (HP:0003200) | 2.69816399 |
| 67 | Hyperglycinuria (HP:0003108) | 2.63578147 |
| 68 | Ventricular arrhythmia (HP:0004308) | 2.63572528 |
| 69 | Abnormal atrioventricular conduction (HP:0005150) | 2.62181869 |
| 70 | Difficulty running (HP:0009046) | 2.59088228 |
| 71 | Generalized muscle weakness (HP:0003324) | 2.57674313 |
| 72 | Lower limb amyotrophy (HP:0007210) | 2.55284248 |
| 73 | Increased intramyocellular lipid droplets (HP:0012240) | 2.54706490 |
| 74 | Scapular winging (HP:0003691) | 2.51257295 |
| 75 | Progressive macrocephaly (HP:0004481) | 2.50670283 |
| 76 | Hyperammonemia (HP:0001987) | 2.49685666 |
| 77 | Abnormality of glycine metabolism (HP:0010895) | 2.44412224 |
| 78 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.44412224 |
| 79 | Increased CSF lactate (HP:0002490) | 2.41816321 |
| 80 | Increased connective tissue (HP:0009025) | 2.41369366 |
| 81 | Calcaneovalgus deformity (HP:0001848) | 2.40091728 |
| 82 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.35827537 |
| 83 | Difficulty climbing stairs (HP:0003551) | 2.34503825 |
| 84 | Respiratory failure (HP:0002878) | 2.32345130 |
| 85 | Esophageal neoplasm (HP:0100751) | 2.24436736 |
| 86 | Neoplasm of head and neck (HP:0012288) | 2.24436736 |
| 87 | Hypokalemic alkalosis (HP:0001949) | 2.23231726 |
| 88 | Lipid accumulation in hepatocytes (HP:0006561) | 2.21592955 |
| 89 | Lactic acidosis (HP:0003128) | 2.20995017 |
| 90 | Gowers sign (HP:0003391) | 2.19068769 |
| 91 | Nausea (HP:0002018) | 2.15897651 |
| 92 | Increased serum pyruvate (HP:0003542) | 2.13217801 |
| 93 | Abnormality of glycolysis (HP:0004366) | 2.13217801 |
| 94 | Limb-girdle muscle atrophy (HP:0003797) | 2.12304515 |
| 95 | Myotonia (HP:0002486) | 2.10237305 |
| 96 | Absent phalangeal crease (HP:0006109) | 2.07725637 |
| 97 | Lethargy (HP:0001254) | 2.06712061 |
| 98 | Deformed tarsal bones (HP:0008119) | 2.05707465 |
| 99 | Weak cry (HP:0001612) | 2.04438278 |
| 100 | Exercise intolerance (HP:0003546) | 2.04088269 |
| 101 | Metabolic acidosis (HP:0001942) | 2.03183850 |
| 102 | Cerebral hemorrhage (HP:0001342) | 2.01735647 |
| 103 | Spinal rigidity (HP:0003306) | 2.01533576 |
| 104 | Goiter (HP:0000853) | 2.01388036 |
| 105 | Vomiting (HP:0002013) | 2.01196437 |
| 106 | Respiratory distress (HP:0002098) | 2.01040980 |
| 107 | Palmoplantar keratoderma (HP:0000982) | 2.00598329 |
| 108 | Pheochromocytoma (HP:0002666) | 2.00031507 |
| 109 | Malignant hyperthermia (HP:0002047) | 1.99363495 |
| 110 | Hypoplastic ischia (HP:0003175) | 1.98753015 |
| 111 | Hyperlipoproteinemia (HP:0010980) | 1.98346187 |
| 112 | Conjunctival hamartoma (HP:0100780) | 1.98139632 |
| 113 | Progressive muscle weakness (HP:0003323) | 1.98020240 |
| 114 | Muscle stiffness (HP:0003552) | 1.97644693 |
| 115 | Distal lower limb muscle weakness (HP:0009053) | 1.96738273 |
| 116 | Xanthomatosis (HP:0000991) | 1.95856189 |
| 117 | Glycosuria (HP:0003076) | 1.95417921 |
| 118 | Abnormality of urine glucose concentration (HP:0011016) | 1.95417921 |
| 119 | Proximal amyotrophy (HP:0007126) | 1.92974648 |
| 120 | Left ventricular hypertrophy (HP:0001712) | 1.92043672 |
| 121 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.90715146 |
| 122 | Hypoalphalipoproteinemia (HP:0003233) | 1.89922574 |
| 123 | Muscular dystrophy (HP:0003560) | 1.83510906 |
| 124 | Waddling gait (HP:0002515) | 1.83223347 |
| 125 | Pulmonary artery stenosis (HP:0004415) | 1.83152772 |
| 126 | Abnormal EKG (HP:0003115) | 1.83018968 |
| 127 | Neurofibrillary tangles (HP:0002185) | 1.82842470 |
| 128 | Renal Fanconi syndrome (HP:0001994) | 1.82090496 |
| 129 | Neuroendocrine neoplasm (HP:0100634) | 1.81148885 |
| 130 | Fetal akinesia sequence (HP:0001989) | 1.80710940 |
| 131 | Tinnitus (HP:0000360) | 1.80699793 |
| 132 | Increased hepatocellular lipid droplets (HP:0006565) | 1.79524879 |
| 133 | Steppage gait (HP:0003376) | 1.78933427 |
| 134 | Proximal tubulopathy (HP:0000114) | 1.78637843 |
| 135 | Ventricular fibrillation (HP:0001663) | 1.78534042 |
| 136 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.78472231 |
| 137 | Peripheral hypomyelination (HP:0007182) | 1.77258391 |
| 138 | Abnormality of the ischium (HP:0003174) | 1.75063435 |
| 139 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.74888045 |
| 140 | Sudden cardiac death (HP:0001645) | 1.74842828 |
| 141 | Bone cyst (HP:0012062) | 1.74583626 |
| 142 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.72183198 |
| 143 | Large for gestational age (HP:0001520) | 1.72062374 |
| 144 | Methylmalonic aciduria (HP:0012120) | 1.71525273 |
| 145 | Slender build (HP:0001533) | 1.68351806 |
| 146 | Achilles tendon contracture (HP:0001771) | 1.66119008 |
| 147 | Hip contracture (HP:0003273) | 1.63979457 |
| 148 | Hyperkalemia (HP:0002153) | 1.59328727 |
| 149 | Cerebral aneurysm (HP:0004944) | 1.58769889 |
| 150 | Abnormal finger flexion creases (HP:0006143) | 1.58216571 |
| 151 | Fatigable weakness (HP:0003473) | 1.57493085 |
| 152 | Abnormality of the neuromuscular junction (HP:0003398) | 1.57493085 |
| 153 | Abnormality of the Achilles tendon (HP:0005109) | 1.53767146 |
| 154 | Abnormality of the salivary glands (HP:0010286) | 1.53414223 |
| 155 | Generalized amyotrophy (HP:0003700) | 1.51728756 |
| 156 | Stridor (HP:0010307) | 1.49430960 |
| 157 | Limb-girdle muscle weakness (HP:0003325) | 1.49097022 |
| 158 | Hypoplasia of the iris (HP:0007676) | 1.47910442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 4.16948949 |
| 2 | TTN | 3.99376972 |
| 3 | PHKG1 | 3.27571736 |
| 4 | PHKG2 | 3.27571736 |
| 5 | BCKDK | 3.24427284 |
| 6 | MYLK | 3.20185423 |
| 7 | MUSK | 2.63004663 |
| 8 | TRIB3 | 2.53070710 |
| 9 | STK39 | 2.29276973 |
| 10 | WNK4 | 2.26961152 |
| 11 | OBSCN | 2.19776752 |
| 12 | EPHB1 | 2.14259376 |
| 13 | PINK1 | 2.02544012 |
| 14 | TIE1 | 1.98772366 |
| 15 | PDK2 | 1.95430362 |
| 16 | PDK4 | 1.91833433 |
| 17 | PDK3 | 1.91833433 |
| 18 | DMPK | 1.87781877 |
| 19 | MARK1 | 1.79196001 |
| 20 | PIK3CA | 1.74477512 |
| 21 | PBK | 1.62869657 |
| 22 | GRK7 | 1.52122189 |
| 23 | ERN1 | 1.50589759 |
| 24 | MAPKAPK3 | 1.42035014 |
| 25 | ICK | 1.40898734 |
| 26 | PKN2 | 1.37671142 |
| 27 | PIK3CG | 1.37607941 |
| 28 | PKN1 | 1.35785264 |
| 29 | INSRR | 1.27867669 |
| 30 | PRKD1 | 1.27439538 |
| 31 | TRPM7 | 1.27058710 |
| 32 | EPHA4 | 1.23517849 |
| 33 | PAK6 | 1.19730431 |
| 34 | LIMK1 | 1.19160858 |
| 35 | PRKD3 | 1.18307116 |
| 36 | STK24 | 1.18305143 |
| 37 | SIK1 | 1.17323583 |
| 38 | PAK3 | 1.17283974 |
| 39 | PRPF4B | 1.15626352 |
| 40 | ILK | 1.15174169 |
| 41 | CAMK2D | 1.13571208 |
| 42 | MAP3K3 | 1.13431060 |
| 43 | DDR2 | 1.08637566 |
| 44 | IRAK3 | 1.06528619 |
| 45 | MST4 | 1.05178174 |
| 46 | TBK1 | 1.04628800 |
| 47 | TGFBR2 | 0.99647364 |
| 48 | LATS2 | 0.95117180 |
| 49 | EEF2K | 0.94629519 |
| 50 | NTRK3 | 0.93481353 |
| 51 | MAP3K6 | 0.93400784 |
| 52 | PRKG2 | 0.93108684 |
| 53 | KSR2 | 0.92582577 |
| 54 | DAPK2 | 0.91880074 |
| 55 | MAPK12 | 0.91142368 |
| 56 | MST1R | 0.90934090 |
| 57 | OXSR1 | 0.90843772 |
| 58 | CAMK1 | 0.88576379 |
| 59 | UHMK1 | 0.84868551 |
| 60 | CAMK2B | 0.83179514 |
| 61 | ABL2 | 0.83035998 |
| 62 | NME2 | 0.82698728 |
| 63 | MAP3K11 | 0.82271388 |
| 64 | ROCK1 | 0.81883460 |
| 65 | CAMK4 | 0.80914591 |
| 66 | DAPK3 | 0.79171796 |
| 67 | ROCK2 | 0.76046444 |
| 68 | MET | 0.75819493 |
| 69 | PRKCE | 0.74799822 |
| 70 | MAP2K6 | 0.74470418 |
| 71 | STK4 | 0.73553397 |
| 72 | RIPK1 | 0.72306887 |
| 73 | PDPK1 | 0.71802291 |
| 74 | LRRK2 | 0.69708533 |
| 75 | TESK1 | 0.69497810 |
| 76 | SGK3 | 0.69062620 |
| 77 | MAPKAPK5 | 0.68536936 |
| 78 | ARAF | 0.68424404 |
| 79 | AKT2 | 0.67286537 |
| 80 | MARK2 | 0.66664751 |
| 81 | PRKAA2 | 0.65424822 |
| 82 | MAP2K3 | 0.63233987 |
| 83 | WNK1 | 0.62882378 |
| 84 | MAP2K4 | 0.60005487 |
| 85 | MAPK7 | 0.59678136 |
| 86 | MAPK4 | 0.57982038 |
| 87 | MAP3K1 | 0.57000376 |
| 88 | MAP2K1 | 0.56208618 |
| 89 | JAK1 | 0.56158462 |
| 90 | MAP3K14 | 0.55889806 |
| 91 | CAMK1D | 0.55839744 |
| 92 | IRAK1 | 0.55762407 |
| 93 | NTRK1 | 0.54808069 |
| 94 | PDGFRB | 0.53423518 |
| 95 | DYRK1B | 0.52877793 |
| 96 | TAOK2 | 0.52139448 |
| 97 | CAMK2G | 0.51601811 |
| 98 | PRKCQ | 0.51567768 |
| 99 | NEK9 | 0.50599556 |
| 100 | MOS | 0.50514854 |
| 101 | IRAK2 | 0.50205286 |
| 102 | BLK | 0.49064107 |
| 103 | MAPK10 | 0.48856973 |
| 104 | PDGFRA | 0.48778602 |
| 105 | NEK1 | 0.48316312 |
| 106 | MAP3K13 | 0.48224428 |
| 107 | SGK2 | 0.48098858 |
| 108 | KDR | 0.48021658 |
| 109 | EPHA3 | 0.47846096 |
| 110 | IRAK4 | 0.47621775 |
| 111 | PTK6 | 0.47487852 |
| 112 | CAMK2A | 0.46565165 |
| 113 | PRKG1 | 0.46244776 |
| 114 | SGK1 | 0.45866506 |
| 115 | CDK5 | 0.45754567 |
| 116 | FGFR4 | 0.45442858 |
| 117 | RPS6KA6 | 0.44969384 |
| 118 | CDC42BPA | 0.44916201 |
| 119 | PRKACG | 0.44440251 |
| 120 | BMX | 0.44253015 |
| 121 | PRKAA1 | 0.44142853 |
| 122 | MAPK11 | 0.43856124 |
| 123 | IKBKE | 0.43285570 |
| 124 | NTRK2 | 0.42097627 |
| 125 | RPS6KA3 | 0.41705255 |
| 126 | FGFR3 | 0.41665033 |
| 127 | RPS6KC1 | 0.41185380 |
| 128 | RPS6KL1 | 0.41185380 |
| 129 | STK38L | 0.40974352 |
| 130 | PRKACA | 0.40804149 |
| 131 | MAPK15 | 0.40745322 |
| 132 | CSK | 0.40742858 |
| 133 | SGK223 | 0.40001820 |
| 134 | SGK494 | 0.40001820 |
| 135 | TYRO3 | 0.39626303 |
| 136 | TYK2 | 0.38844850 |
| 137 | PDK1 | 0.38602558 |
| 138 | JAK2 | 0.38192819 |
| 139 | PRKCD | 0.37203763 |
| 140 | GSK3A | 0.35431707 |
| 141 | RIPK4 | 0.35217835 |
| 142 | PRKCH | 0.33959277 |
| 143 | MAP2K2 | 0.33833793 |
| 144 | CAMKK1 | 0.33562580 |
| 145 | MAP3K7 | 0.33436158 |
| 146 | PRKACB | 0.32104508 |
| 147 | RET | 0.31993274 |
| 148 | PTK2B | 0.31810136 |
| 149 | MAP3K9 | 0.30923495 |
| 150 | EPHB2 | 0.30647646 |
| 151 | NME1 | 0.30316030 |
| 152 | STK38 | 0.30294287 |
| 153 | MAP3K2 | 0.29412867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.29418281 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.22358047 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.18818252 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.94902362 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.92390856 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.74332393 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.49645174 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.49588046 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.36359669 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.36071228 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.28312308 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.06565520 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.04289437 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.94399917 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92755606 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89470503 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.89236706 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.85769482 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.74945605 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.74797212 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.73982607 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71867058 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66642435 |
| 24 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.65673816 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.62198678 |
| 26 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.61504767 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.56936695 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.55565577 |
| 29 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.51777429 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45242892 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43142726 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42722747 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.40228457 |
| 34 | Long-term potentiation_Homo sapiens_hsa04720 | 1.39706790 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35925537 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.35634956 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.31308117 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26151597 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.25164654 |
| 40 | Renin secretion_Homo sapiens_hsa04924 | 1.24651766 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24345267 |
| 42 | Insulin secretion_Homo sapiens_hsa04911 | 1.23251107 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21785759 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19497522 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18349402 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17754570 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14754560 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10809401 |
| 49 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.09953598 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08976209 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07173338 |
| 52 | Circadian entrainment_Homo sapiens_hsa04713 | 1.05222202 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05048295 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03949181 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03365228 |
| 56 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.00911920 |
| 57 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.99931495 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98701112 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98414124 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97510651 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89028011 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88952773 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88770122 |
| 64 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.86756645 |
| 65 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.85003452 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84500484 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.83237556 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79536008 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79241597 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.78137781 |
| 71 | GABAergic synapse_Homo sapiens_hsa04727 | 0.77918147 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74581082 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73636108 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72594996 |
| 75 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72023504 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71866565 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70909610 |
| 78 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69344444 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67739264 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67070612 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63681848 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62422584 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.61718171 |
| 84 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61418833 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61183248 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.61047802 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60748661 |
| 88 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59504099 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.59435059 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59288589 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58219051 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.57945948 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.57287660 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56305834 |
| 95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55933399 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55585009 |
| 97 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.54495279 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54103326 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.54013715 |
| 100 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.53491203 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52663232 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52647414 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51625874 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51108925 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48714658 |
| 106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47352266 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46938991 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45690889 |
| 109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.44752972 |
| 110 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44687011 |
| 111 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42899642 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42755655 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41634502 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.41436010 |
| 115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40295627 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39859705 |
| 117 | Gap junction_Homo sapiens_hsa04540 | 0.39405387 |
| 118 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39221358 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38022574 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.37657890 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37463029 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36999528 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36716408 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34952930 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34915306 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34735535 |
| 127 | Phagosome_Homo sapiens_hsa04145 | 0.34611233 |
| 128 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.33676438 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33329083 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.33230999 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.31801357 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31711746 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31399188 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31099817 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31031559 |
| 136 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.29420785 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.29164400 |
| 138 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26338485 |
| 139 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.25822733 |
| 140 | Long-term depression_Homo sapiens_hsa04730 | 0.25175474 |
| 141 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.24815025 |
| 142 | Lysine degradation_Homo sapiens_hsa00310 | 0.24561476 |
| 143 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.22950551 |
| 144 | Focal adhesion_Homo sapiens_hsa04510 | 0.22445981 |
| 145 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22166945 |
| 146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20649129 |
| 147 | Leishmaniasis_Homo sapiens_hsa05140 | 0.19055972 |
| 148 | Protein export_Homo sapiens_hsa03060 | 0.18657141 |
| 149 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.15315368 |
| 150 | Pertussis_Homo sapiens_hsa05133 | 0.14664190 |
| 151 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.13656659 |
| 152 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.12648244 |

